|
Adverse event (AE) management in patients (pts) with relapsed and refractory multiple myeloma (RRMM) taking pomalidomide (POM) plus low dose-dexamethasone (LoDEX): A pooled analysis from 3 clinical trials. |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda |
|
|
Honoraria - Amgen; Celgene; Janssen; Novartis |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genmab; Johnson & Johnson; Millennium; Novartis; Oncopeptides |
Research Funding - Celgene; Millennium |
|
David Samuel DiCapua Siegel |
Stock and Other Ownership Interests - COTA |
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Novartis; Onyx; Sanofi |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Onyx |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda |
Research Funding - Celgene; Janssen |
|
|
Honoraria - Amgen; Celgene; Janssen; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
Research Funding - Celgene |
|
|
Honoraria - Amgen; Celgene; Takeda |
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Takeda |
Speakers' Bureau - Bristol-Myers Squibb; Celgene |
Research Funding - Celgene; Janssen |
|
|
Honoraria - Amgen; Celgene; Janssen |
Consulting or Advisory Role - Amgen; Celgene; Janssen |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Millennium; MSD; Novartis; Onyx |